Saturday, April 13, 2013

• Sirtex Completes Patient Recruitment for SIRFLOX Study Evaluating SIR-Spheres® Microspheres as First-Line Treatment for Colorectal Liver MetastasesBusiness Wire( (Sat, Apr 13)

Monday, March 4, 2013

• Sirtex Medical Inc. Announces Half-Year Dose Sales ReportBusiness Wire( (Mon, Mar 4)

Tuesday, February 19, 2013

• Sirtex Medical Inc. Hosts Dinner Symposium at the 2013 American Hepato-Pancreato-Biliary Association’s Annual MeetingBusiness Wire( (Tue, Feb 19)

Thursday, February 14, 2013

• Sirtex Medical: Interim report – half-year ended 31 December 2012Business Wire( (Thu, Feb 14)

Thursday, January 24, 2013

• Large U.S. Multi-Center Study Supports the Safety and Efficacy of Sirtex’s SIR-Spheres® microspheres in Treating Colorectal Liver MetastasesBusiness Wire( (Thu, Jan 24)

Tuesday, January 15, 2013

• Sirtex Medical Inc. Announces Second Quarter Sales GrowthBusiness Wire( (Tue, Jan 15)